|
|
Office Locations:
|
25 Deforest Avenue, Suite 108
Summit, NJ 07901
Phone: 212-508-7090
| | |
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
Software & Internet
|
|
|
|
Concord Health Partners is a healthcare focused investment firm with a strategic model that optimizes the alignment of interests between investors and portfolio companies. Concord is primarily focused on investing in healthcare companies that have the potential to enhance the value of care through products, services, technologies and solutions that lower costs, improve quality and/or expand access to care. Investments are made across a range of subsectors including: Healthcare services, Healthcare information technology, Medical technology, Medical devices, Diagnostics, and Healthcare business support services. The American Hospital Association's AHA Innovation Development Fund, LP, is a $50 million venture capital fund sponsored and managed by Concord Health Partners. The goal of the AHA Fund is to invest in early-stage health care companies that provide products, services and solutions that help hospitals and health systems transform care delivery.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
